Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?

This publication has 153 references indexed in Scilit:

• [2,4-13C]β-hydroxybutyrate Metabolism in Astrocytes and C6 Glioblastoma Cells
  Neurochemical Research, 2011
• Perspectives on the mesenchymal origin of metastatic cancer
  Cancer and Metastasis Reviews, 2010
• Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
  Cancer Cell, 2010
• American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13–15, 2009, San Diego, CA
  Journal of Neuro-Oncology, 2010
• Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor model
  International Journal of Cancer, 2010
• Mitochondrial gateways to cancer
  Molecular Aspects of Medicine, 2010
• Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
  Breast Cancer Research and Treatment, 2009
• Mitochondrial Dysfunction Leads to Nuclear Genome Instability via an Iron-Sulfur Cluster Defect
  Cell, 2009
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
  The Lancet Oncology, 2009
• The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
  Brain Research Reviews, 2009